loading...| Preferred Name |
abemaciclib |
| Synonyms |
LY2835219 |
| ID |
http://purl.bioontology.org/ontology/MESH/C000590451 |
| altLabel |
LY2835219 abemaciclib mesylate 5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine 5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl)amine Verzenio LY-2835219 LY2385219 LY2835210 |
| cui |
C5206609 C4529617 C3852841 C3852839 C5543766 |
| HM |
D000631 D001562 |
| Inverse of RB |
KKT462Q807 0 60UAB198HK |
| LT |
TRD |
| Mapped to | |
| MDA |
20140807 |
| MeSH Frequency |
261 |
| MMR |
20210223 |
| notation |
C000590451 |
| prefLabel |
abemaciclib |
| RR |
KKT462Q807 |
| SC |
1 |
| Scope Statement |
a cell cycle inhibitor |
| SRC |
J Natl Cancer Inst. 2014 Jul;106(7):doi: 10.1093/jnci/dju221. |
| TERMUI |
T001098776 T000864035 T000864036 T000993830 T000864037 T001098782 T000864034 T000879082 T000879079 |
| TH |
NLM (2021) NLM (2015) FDA SRS (2017) NLM (2014) NLM (2020) |
| tui |
T109 T121 |